Study S002814

A Randomized, Open-label, Single-dose, Parallel Comparison Study to Evaluate the Bioequivalence of GZR18 Injection Before and After CMC Change in Healthy Adult Male Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07355738
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: RECRUITING
Enrollment: 138
Start: 2026-01-09
Primary completion: 2026-05-20
Lead sponsor: Gan & Lee Pharmaceuticals.
Conditions: Obesity&T2D
Interventions: DRUG:GZR18 injection A; DRUG:GZR18 injection B
Results posted: FALSE

Registered primary outcomes

the maximum concentration (Cmax) [Day1-Day36]
the area under the concentration-time curve during a dosing interval (AUC0-t) [Day1-Day36]
the area under the concentration-time curve from the time of dosing extrapolated to infinity (AUC0-∞) [Day1-Day36]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.